TripAdvisor (TRIP)
(Delayed Data from NSDQ)
$26.15 USD
+0.03 (0.11%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $26.14 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
TRIP 26.15 +0.03(0.11%)
Will TRIP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TRIP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TRIP
TRIP vs. AMZN: Which Stock Should Value Investors Buy Now?
Play Likely Earnings Beat With 5 Top-Ranked Stocks
TRIP: What are Zacks experts saying now?
Zacks Private Portfolio Services
4 Solid Stocks to Buy as E-Commerce Boosts Retail Sales
Forget Inflation, Retail Sales Stage a Solid Rebound: 5 Winners
TripAdvisor (TRIP) is a Top-Ranked Value Stock: Should You Buy?
Other News for TRIP
TripAdvisor price target raised by $2 at Jefferies, here's why
Tripadvisor still seeing sales interest from Apollo, others - report
Tripadvisor to Host First Quarter 2024 Conference Call on May 8, 2024
July 19th Options Now Available For Tripadvisor (TRIP)
Red Light Holland Advances Psychedelic Research